1Casillas LF, Cheife Z, Doady J, et al. Betaglycan presents ligand to the TGF -β signaling receptor[ J ]. Cell, 1993,73 : 1435 - 1445.
2Goodman LV, Majack PA. Vascular smooth muscle cells express distinc transforming growth factor-β phenotypes as a function of cell density in culture[J].Biol Chem,1989,264:5241 - 5244.
3Ilkedo H, Tamaki K, Ueda S, et al.Smad protein and TGF - beta signaling in vascular smooth muscle cells[ J ]. Mol Med, 2003,11:645- 650.
4Stouffer GA, Owens C,K. TGF - beta promotes proliferation of cultured SMC via both PDGF- AA - dependent and PDGF- AA - independent mechanisms[ J]. Clin Invest,1994,93:2048-2055.
5Sakakibara K, Kubota K,Worku B, et al.TGF- beta inhibits vascular smooth muscle cell proliferation through down regulation of cyclin A [ J ]. Slag Res, 2003,114: 283 -292.
6Grainger DJ, Kemp PR, Witchell CM, et al. Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase [J].Biochem, 1994,299:227- 235.
7Kei Yamamoto, Ryuichi Morishita, Naruya T, et al. Ribozyme Oligonucleotides against transforming growth factor - β inhibited neointimal formation after vascular injury in rat model [J] .Circulation,2000,102: 1308- 1314.
8Smith JD, Bryant SR, Couper LL, et al. Soluble transforming growth factor - β type Ⅱ receptor inhibit negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth[J].Cir Res, 1999,84:1212- 1222.
9Yi Shi, Janes EO brien, Ali Fard, et al.Adventitial myofibroblast contribute to neointimal formation in injured porcine coronary arteries [J] .Ciruculation , 1996,94:1655- 1664.
10Sehgal I, Thompson TC.Novel regulation of type Ⅳ collagense (matrix metanoproteinase - 9 and - 2) by transforming growth factor - β1 in human prostate cancer cell line[ J].Mol Biol Cell, 1999,10:407-416.
1Bhoday J,de Silva S,Xu Q.The molecular mechanisms of vascular restenosis:Which genes are crucial?[J].Curr Vasc Pharmacol,2006,4(3):269-275.
2Yamamoto K,Morishita R,Tomita N,et al.Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model:potential application of ribozyme strategy to treat cardiovascular disease[J].Circulation,2000,102(11):1308-1314.
3Mann BK,Schmedlen RH,West JL.Tethered TGF-beta increases extracellular matrix production of vascular smooth muscle cells[J].Biomaterials,2001,22(5):439-444.
4Ryan ST,Koteliansky VE,Gotwals PJ,et al.Transforming growth factor-beta dependent events in vascular remodeling following arterial injury[J].J Vasc Res,2003,40(1):37-46.
